Assignee
SHANGHAI YUANXI MEDICINE CORP
CN·1 granted patent·1 pending application·0 citations·filing 2020–2021
Top patents by PatentIndex Score
2 records- 0141US11952356B2Crystalline form of 1,4-bis[1,2-benzisoselenazol-3(2H)-one]-butane, method for preparing same and use thereofSHANGHAI YUANXI MEDICINE CORP·Filed 2020·Granted Apr 9, 2024·0 cites·16 claims
- 0238US2023210819A1Use of benzisoselazole derivative for anti-coronavirus and control of interstitial lung disease (ild) related to coronavirusSHANGHAI YUANXI MEDICINE CORP·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI YUANXI MEDICINE CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →